Omics Approaches on Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets, 3rd Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 833
Special Issue Editor
2. School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, UK
Interests: tumor immunology; autoimmunity; RNA sequencing; immunotranscriptomics; translational oncology; immunoregulatory cytokines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Currently, chronic immune-mediated inflammatory diseases (IMIDs), including, but not restricted to, autoimmune conditions, which present ever-increasing prevalence worldwide. Rheumatoid and psoriatic arthritis, systemic lupus erythematosus, inflammatory bowel disease, Crohn’s disease, ulcerative colitis, multiple sclerosis, and others affect a significant proportion of human population. In addition to the irreversible impairment of the target tissue, IMIDs may also be accompanied by life-threatening comorbidities, such as cardiovascular disease and neoplasia development, while their course is characterized by relapsing exacerbations leading to life-long morbidity. Unfortunately, current therapeutics are not able to efficiently manage all patients and there is a significant proportion of non-responders; this is possibly associated with the remaining missing insights regarding their underlying pathophysiology.
Recent technological advances facilitated high-throughput omics approaches (genomics, transcriptomics, epigenomics, proteomics, and metabolomics) for the evaluation of critical molecular compartments involved in the development and perpetuation of IMIDs. Unveiling key players governing their pathogenesis and progression may pave the way for the detection of novel biomarkers for disease prognosis and response-to-therapy monitoring, while suggesting potential therapeutic targets.
Bulk and single-cell omics, multi-omics flow cytometry, new-generation microscopy, and systems biology are among the current approaches expected to provide useful tools for applications in daily clinical practice and the improvement of patient management and quality of life.
After having success in collecting significant number of valuable manuscripts, this Special Issue of Biomedicines, titled “Omics Approaches on Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets, 3rd Edition”, is now launching its third volume, aiming at hosting more original research, reviews, or systematic review articles describing the most recent advances in the field of omics on IMIDs, possibly suggesting novel biomarkers and/or therapeutic targets.
Dr. Maria-Ioanna Christodoulou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- IMIDs
- IBD
- Crohn’s disease
- ulcerative colitis
- SLE
- Sjogren’s syndrome
- rheumatoid arthritis
- psoriatic arthritis
- multiple sclerosis
- bulk and single-cell omics
- multi-omics flow cytometry
- next-generation microscopy
- tissue microarrays
- systems biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
